Chongqing Taiji Industry(Group)Ltd Future Growth
Future criteria checks 4/6
Chongqing Taiji Industry(Group)Ltd is forecast to grow earnings and revenue by 22.5% and 13.2% per annum respectively. EPS is expected to grow by 22.5% per annum. Return on equity is forecast to be 23% in 3 years.
Key information
22.5%
Earnings growth rate
22.5%
EPS growth rate
Pharmaceuticals earnings growth | 18.3% |
Revenue growth rate | 13.2% |
Future return on equity | 23.0% |
Analyst coverage | Good |
Last updated | 14 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Take Care Before Jumping Onto Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) Even Though It's 27% Cheaper
Jul 04Is Chongqing Taiji Industry(Group)Ltd (SHSE:600129) Using Too Much Debt?
Jul 03Investors Shouldn't Be Too Comfortable With Chongqing Taiji Industry(Group)Ltd's (SHSE:600129) Earnings
May 02Is Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) Trading At A 33% Discount?
Mar 18Chongqing Taiji Industry(Group)Ltd (SHSE:600129) Has A Pretty Healthy Balance Sheet
Feb 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 22,409 | 1,588 | 1,463 | 2,065 | 6 |
12/31/2025 | 20,091 | 1,326 | 1,534 | 1,968 | 6 |
12/31/2024 | 17,834 | 1,071 | 1,326 | 1,347 | 6 |
3/31/2024 | 15,403 | 834 | -185 | 672 | N/A |
12/31/2023 | 15,623 | 822 | -164 | 672 | N/A |
9/30/2023 | 15,677 | 858 | 215 | 865 | N/A |
6/30/2023 | 15,929 | 792 | 464 | 1,047 | N/A |
3/31/2023 | 15,020 | 568 | 1,093 | 1,663 | N/A |
12/31/2022 | 14,127 | 354 | 1,249 | 1,781 | N/A |
9/30/2022 | 13,212 | -516 | 393 | 947 | N/A |
6/30/2022 | 12,956 | -472 | 302 | 841 | N/A |
3/31/2022 | 12,386 | -527 | 327 | 839 | N/A |
12/31/2021 | 12,149 | -523 | 59 | 559 | N/A |
9/30/2021 | 12,133 | 298 | 164 | 978 | N/A |
6/30/2021 | 11,897 | 133 | 158 | 919 | N/A |
3/31/2021 | 11,822 | 122 | -127 | 657 | N/A |
12/31/2020 | 11,208 | 66 | -52 | 750 | N/A |
9/30/2020 | 11,297 | -178 | -939 | 40 | N/A |
6/30/2020 | 11,248 | -150 | -869 | 89 | N/A |
3/31/2020 | 11,219 | -207 | -909 | 2 | N/A |
12/31/2019 | 11,643 | -71 | -659 | 327 | N/A |
9/30/2019 | 11,937 | 48 | -494 | 201 | N/A |
6/30/2019 | 11,693 | 105 | -580 | 187 | N/A |
3/31/2019 | 11,546 | 164 | -597 | 180 | N/A |
12/31/2018 | 10,689 | 70 | -587 | 104 | N/A |
9/30/2018 | 9,893 | 166 | -637 | -124 | N/A |
6/30/2018 | 9,475 | 117 | -609 | -42 | N/A |
3/31/2018 | 9,155 | 107 | -578 | -23 | N/A |
12/31/2017 | 8,773 | 98 | N/A | -126 | N/A |
9/30/2017 | 8,857 | 4 | N/A | -77 | N/A |
6/30/2017 | 8,509 | -73 | N/A | 4 | N/A |
3/31/2017 | 8,121 | -61 | N/A | -82 | N/A |
12/31/2016 | 7,952 | 856 | N/A | -108 | N/A |
9/30/2016 | 7,488 | 959 | N/A | -125 | N/A |
6/30/2016 | 7,211 | 1,016 | N/A | -272 | N/A |
3/31/2016 | 7,128 | 1,131 | N/A | -217 | N/A |
12/31/2015 | 7,171 | 232 | N/A | -65 | N/A |
9/30/2015 | 7,232 | -97 | N/A | -289 | N/A |
6/30/2015 | 7,108 | -120 | N/A | -284 | N/A |
3/31/2015 | 7,035 | -263 | N/A | -263 | N/A |
12/31/2014 | 6,958 | -277 | N/A | -276 | N/A |
9/30/2014 | 6,623 | 5 | N/A | -138 | N/A |
6/30/2014 | 6,850 | 15 | N/A | -134 | N/A |
3/31/2014 | 6,639 | 8 | N/A | -138 | N/A |
12/31/2013 | 6,603 | 13 | N/A | -139 | N/A |
9/30/2013 | 6,392 | -168 | N/A | 86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600129's forecast earnings growth (22.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 600129's earnings (22.5% per year) are forecast to grow faster than the CN market (22% per year).
High Growth Earnings: 600129's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 600129's revenue (13.2% per year) is forecast to grow slower than the CN market (13.4% per year).
High Growth Revenue: 600129's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600129's Return on Equity is forecast to be high in 3 years time (23%)